Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
BioPhy has introduced an innovative AI operating system aimed at significantly expediting the identification and development of promising drug candidates....
Pfizer has announced the FDA's approval of PENBRAYA™, an innovative pentavalent vaccine. PENBRAYA™ is the first and only vaccine designed to safeguard adolescents and young adults, aged 10 to 25...
Tiziana Life Sciences, a biotechnology company specializing in innovative immunomodulation therapies, has reached a significant milestone in the treatment of multiple sclerosis. The U.S. Food and Drug Administration...
Researchers at Purdue University have devised an innovative cancer therapy that employs a unique approach to impede the growth of tumors. This method tricks cancer cells into absorbing a fragment of RNA, which naturally hampers their ability to divide....
Citius Pharmaceuticals, has shared a significant update regarding the progress of their product denileukin diftitox ("LYMPHIRTM") through the FDA approval process. The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter in response to the Company's application seeking approval for LYMPHIRTM....
Ipsen has officially received approval from the U.S. Food and Drug Administration (FDA) for Sohonos™ (palovarotene) capsules....
Pfizer has just received accelerated approval from the U.S. Food and Drug Administration (FDA) for its ELREXFIO™ (elranatamab-bcmm) to treat adult patients dealing with relapsed or refractory multiple myeloma (RRMM)....
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, has introduced XACDURO® (sulbactam for injection; durlobactam for injection) to the U.S. market, making it available for individuals aged 18 and above....
Sandoz, a prominent player in the global pharmaceutical industry specializing in generic and biosimilar medicines, has announced a significant milestone. The US Food and Drug Administration (FDA) has granted its approval for Tyruko® (natalizumab-sztn), a biosimilar developed in collaboration with Polpharma Biologics....
CyGenica Limited, a dynamic biotech startup, has achieved a significant milestone in the battle against Glioblastoma Multiforme (GBM), an aggressive form of brain cancer....
